EGFR mutations could be predicted by the necrosis/contrast enhancing (AUC = 0.68, p = 0.001) ratio and contrast enhancing/tumor bulk (AUC = 0.68, p = 0.001) ratio. This evidence concerns the gene EGFR and neoplasm.